Recovery of Corneal Sensitivity and Increase in Nerve Density and Wound Healing in Diabetic Mice After PEDF Plus DHA Treatment.
| Autor: | Jiucheng He, Thang Luong Pham, Azucena Kakazu, Bazan, Haydee E. P., He, Jiucheng, Pham, Thang Luong, Kakazu, Azucena |
|---|---|
| Předmět: |
DOCOSAHEXAENOIC acid
PIGMENT epithelium-derived factor CORNEA injuries WOUND healing PEOPLE with diabetes LABORATORY mice THERAPEUTICS THERAPEUTIC use of proteins ANIMAL experimentation COMBINATION drug therapy CORNEA DIABETES MICE NERVE growth factor PROTEINS RESEARCH funding TEARS (Body fluid) INNERVATION |
| Zdroj: | Diabetes; Sep2017, Vol. 66 Issue 9, p2511-2520, 10p, 1 Color Photograph, 2 Black and White Photographs, 1 Diagram, 2 Graphs |
| Abstrakt: | Diabetic keratopathy decreases corneal sensation and tear secretion and delays wound healing after injury. In the current study, we tested the effect of treatment with pigment epithelium-derived factor (PEDF) in combination with docosahexaenoic acid (DHA) on corneal nerve regeneration in a mouse model of diabetes with or without corneal injury. The study was performed in streptozotocin-induced diabetic mice (C57BL/6). Ten weeks after streptozotocin injection, diabetic mice showed significant decreases of corneal sensitivity, tear production, and epithelial subbasal nerve density when compared with age-matched normal mice. After diabetic mice were wounded in the right eye and treated in both eyes with PEDF+DHA for 2 weeks, there was a significant increase in corneal epithelial nerve regeneration and substance P-positive nerve density in both wounded and unwounded eyes compared with vehicle-treated corneas. There also was elevated corneal sensitivity and tear production in the treated corneas compared with vehicle. In addition, PEDF+DHA accelerated corneal wound healing, selectively recruited type 2 macrophages, and prevented neutrophil infiltration in diabetic wounded corneas. These results suggest that topical treatment with PEDF+DHA promotes corneal nerve regeneration and wound healing in diabetic mice and could potentially be exploited as a therapeutic option for the treatment of diabetic keratopathy. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|